Episode 188: Vasopressors

We go over the essential and complex topic of vasopressors in the ED. Hosts: Brian Gilberti, MD Catherine Jamin, MD https://media.blubrry.com/coreem/content.blubrry.com/coreem/Vasopressors.mp3 Download Leave a Comment Tags: Critical Care Show Notes Introduction Host: Brian Gilberti, MD Guest: Catherine Jamin, MD Associate professor of Emergency Medicine at NYU Langone Health Vice Chair of Operations Triple-boarded in Emergency Medicine, Internal Medicine, and Critical Care Medicine Topic: Vasopressors: Essential agents for supporting critically ill patients in the ED What Are Vasopressors and When to Use Them Two primary mechanisms to increase blood pressure: Increasing systemic vascular resistance via vasoconstriction Increasing cardiac output via augmenting inotropy and chronotropy Indicators for vasopressor use: MAP Signs of organ dysfunction like altered mental status, decreased urine output, elevated lactate Fluid resuscitation either ineffective or contraindicated (e.g., in CHF patients) Commonly Used Vasopressors in the ED Norepinephrine Epinephrine Vasopressin Phenylephrine Norepinephrine Mechanism: Stimulates alpha-1 (vasoconstriction) and beta-1 receptors (increases inotropy & chronotropy) Starting Dose: 10 mcg/min, titrate to MAP >65 Max Dose: No strict limit but usually add a 2nd pressor at 15-20 mcg/min Situational Preference: First-line for most cases of shock (septic, undifferentiated, hypovolemic, cardiogenic) Pros: Can be infused peripherally via large bore IV Vasopressin Mechanism: Activates V1a receptors causing vasoconstriction Dose: Fixed, non-titratable dose of 0.04 units/min Situational Preference: Second-line in septic shock Concerns: Potential for peripheral ischemia Phenylephrine Mechanism: Stimulates alpha-1 receptors causing vasoconstriction Starting Dose: 100 mcg/min, titrate to MAP >65 Situational Preference: High cardiac output states, tachyarrhythmias, peri-intubation Concerns: Increases afterload, can worsen low cardiac output states Epinephrine Mechanism: Stimulates alpha-1, beta-1 and beta-2 receptors Starting Dose: 5-10 mcg/min, titrate to MAP >65 Situational Preference: Anaphylactic shock, septic cardiomyopathy Limitations: Can induce tachycardia, may elevate lactate levels Escalation Strategy in Refractory Shock Norepinephrine -> Vasopressin (with stress dose steroids) -> Epinephrine Consider POCUS, lactate, central venous saturation, and acid-base status Peripheral Pressors Can safely be administered peripherally via large bore IVs in proximal upper extremity Sites: Cephalic or basilic veins Adverse Events: Low at 1.8% based on meta-analysis Actions in case of extravasation: Phentolamine injection, nitroglycerin paste Push-Dose Pressors Primarily Phenylephrine (peri-intubation, during procedures) Also Epinephrine for peri-code situations Doses: Epi – 5-20 mcg every 2-5 min Take-Home Points Most used medications are going to be norepinephrine, vasopressin, phenylephrine, and epinephrine. Consider these medications if there are signs of end-organ dysfunction, there is a considerable delta in baseline BP, systolic is less than 90 and/or MAP is less than 65 Norepinephrine is a good pressor for a lot of the situations that we encounter in the emergency department, such as septic shock, undifferentiated shock and hypovolemic shock. Vasopressin is commonly the second we reach for in most of these scenarios Epinephrine will be first for anaphylactic shock and may be the third agent in septic shock Think about phenylephrine in high-output states (patients with tachydysrhythmias), or with AS, though be cautious in patient with low cardiac output The benefits outweigh risks for peripheral pressors in situations where you promptly have to increase blood pressure while you work on central access Push-dose pressures can help you in a peritinbatuion or pericode situation because it is going to be one of the fastest ways we can boost BP while we work on other measures to stabilize the patient Additional

Listen